Rapports pour BAXTER CORPORATION
Nom de l’entreprise BAXTER CORPORATION |
||
|---|---|---|
Total rapports |
||
Rapports de pénurie |
226 |
|
| Pénurie réelle: | 4 (2%) | |
| Pénurie prévue: | 2 (1%) | |
| Pénurie évitée: | 3 (1%) | |
| Résorbée: | 217 (96%) | |
Rapports de cessation de vente |
28 |
|
| Discontinué sous peu: | 2 (7%) | |
| Discontinué: | 26 (93%) | |
| Renversé: | 0 (0%) | |
Rapports en retard |
16 (6%) |
|
Rapports expirés |
7 (88%) |
|
Rapports de pénurie
| Nom de marque | Concentration(s) | Posologie | État | Date de création | Dernière mise à jour | Rapports |
|---|---|---|---|---|---|---|
| MYXREDLIN | 1UNIT | Solution | Résorbée | 2024-10-24 | 2024-11-12 | 241104 |
| Nitroglycerin in 5% Dextrose Injection | 5G 20MG | Solution | Résorbée | 2019-03-01 | 2019-03-19 | 77245 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML | 5G 40MG | Solution | Résorbée | 2019-05-01 | 2019-05-22 | 82898 |
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION | 0.032MG | Solution | Résorbée | 2024-07-17 | 2024-08-30 | 233218 |
| Nutrineal PD4 Twinbag | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | Liquide | Résorbée | 2018-05-23 | 2018-06-22 | 50095 |
| Nutrineal PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | Liquide | Résorbée | 2018-11-22 | 2019-02-27 | 67436 |
| OLIMEL 4.4% E | 2.64G 0.74G 1.50G 6.41G 8G 154G 3.67G 0.81G 0.52G 2.24G 32G 2.21G 3.07G 2.21G 0.11G 2.64G 4.34G 2.83G 1.28G 2.21G 3.07G 3.07G 2.21G 3.48G 1.75G | Émulsion | Résorbée | 2017-07-10 | 2017-08-16 | 15024 |
| Plasma-Lyte A Injection | 368MG 30MG 37MG 526MG 502MG | Solution | Résorbée | 2019-02-15 | 2019-03-19 | 76031 |
| PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | Solution | Résorbée | 2020-08-17 | 2020-09-01 | 122375 |
| PLASMA-LYTE A | 526MG 368MG 502MG 37MG 30MG | Solution | Résorbée | 2020-08-17 | 2020-08-18 | 122377 |
| PMS-PROPOFOL | 10MG | Émulsion | Résorbée | 2018-03-19 | 2020-06-10 | 43360 |
| PMS-PROPOFOL | 10MG | Émulsion | Résorbée | 2018-03-23 | 2020-06-10 | 43857 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 300MG 900MG | Solution | Résorbée | 2017-05-04 | 2017-09-26 | 9057 |
| Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP | 300MG 900MG 5G | Solution | Résorbée | 2022-02-25 | 2022-03-26 | 155672 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | Solution | Résorbée | 2022-08-31 | 2022-11-02 | 168276 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | Solution | Pénurie réelle | 2025-01-08 | 2025-05-02 | 247098 |
| 10 mmol Potassium Chloride in 100 mL Sterile Water for Injection | 7.46MG | Liquide | Résorbée | 2018-01-12 | 2018-02-06 | 35770 |
| Potassium Chloride 10mmol in 100mL | 7.46MG | Liquide | Résorbée | 2018-08-13 | 2018-08-29 | 58038 |
| Potassium Chloride Injection | 7.46MG | Liquide | Résorbée | 2018-12-14 | 2018-12-20 | 69676 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | Liquide | Résorbée | 2019-07-16 | 2019-11-29 | 89426 |
Rapports de cessation de vente
| Nom de marque | Concentration(s) | Posologie | État | Date de création | Dernière mise à jour | Rapports |
|---|---|---|---|---|---|---|
| tes | 150MG 5G | Solution | Discontinué sous peu | 2025-09-03 | 2025-09-03 | 257296 |
| Chlorure de sodium injectable à 0,9 %, USP | 900MG | Solution | Discontinué | 2020-07-23 | 2020-07-23 | 120955 |
| 0.9% Sodium Chloride Injection, USP | 900MG | Solution | Discontinué | 2020-07-23 | 2020-07-23 | 120952 |
| SODIUM CHLORIDE 1.6% | 1.6G | Solution Solution | Discontinué | 2022-12-13 | 2023-01-01 | 178273 |
| 5% Dextrose Injection, USP | 5G | Solution | Discontinué | 2020-07-23 | 2020-07-23 | 120958 |
| 5% Dextrose Injection, USP | 5G | Solution | Discontinué | 2020-07-23 | 2020-07-23 | 120961 |
| ACID CONCENTRATE 2120 | 67.5G 10.8G 1.61G 7.49G 10.06G 263G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7237 |
| ACID CONCENTRATE 2125 | 89.99G 8.11G 3.21G 7.74G 3.35G 268.24G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7240 |
| ACID CONCENTRATE 2139 | 89.99G 8.11G 3.21G 7.74G 10.06G 268.24G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7243 |
| ACID CONCENTRATE 2152 | 89.99G 8.11G 3.21G 6.24G 6.71G 268.24G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7246 |
| ACID CONCENTRATE 2163 | 90G 10.8G 2.14G 6.24G 10.06G 275G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7249 |
| ACID CONCENTRATE 2171 | 112.53G 5.4G 3.21G 2.5G 8.39G 262.98G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7252 |
| ACID CONCENTRATE 2198 | 10.8G 1.61G 7.49G 10.1G 263G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7255 |
| ACID CONCENTRATE D12292 | 10.8G 1.61G 6.24G 3.35G 263G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7261 |
| ACID CONCENTRATE D12304 | 90G 10.8G 1.61G 7.48G 263G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7264 |
| ACID CONCENTRATE D12306 | 45G 10.8G 1.61G 7.49G 263G | Solution | Discontinué | 2017-04-19 | 2017-12-22 | 7267 |
| CIPROFLOXACIN INJECTION | 2MG | Solution | Discontinué | 2020-07-21 | 2020-08-17 | 120710 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE (300mg/50mL) | 300MG | Solution | Discontinué | 2023-02-06 | 2023-04-02 | 183710 |
| CLINIMIX | 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG | Solution | Discontinué | 2020-06-22 | 2022-04-20 | 118601 |
| CLINIMIX | 520MG 1.04G 1.04G 290MG 290MG 310MG 310MG 5G 240MG 20MG 210MG 90MG 210MG 220MG 230MG | Solution | Discontinué sous peu | 2025-04-10 | 2025-04-10 | 254830 |